RBOT · Vicarious Surgical Inc.
Market Cap
$284,969
Shares
7.12M
Price & Indicators
20d MA
50d MA
200d MA
Earnings
Filing
Insider
Congress
Investor day
Close$0.90
Open$1.20
Day$0.52–1.50
52W close$0.90–13.19
Avg vol 30d85K
Short int136K · 1.9% float · 1.2d
Short vol41%
Last earningsMar 9, 2026
DataJun 2024–Mar 2026
Filing10-Q · Apr 30
Raw chart and full-history price indicators begin at the captured split on Jun 13, 2024; bars on opposite sides are not compared.
Up next
FQ3-26 quarter ends
~Sep 30, 2026
Est
filed Apr 30, 2026
Equibles Rating
blended score · not investment adviceOverall
Strong Sell
SellHoldBuy
Technical
Strong Sell
Momentum
Very Weak
Sentiment
Bearish
Fundamentals
Weak
Quant / Vol
Very High
Market backdrop
VIX 16.3 · calm
Equity put/call 0.67
Technical
price trend
50 / 200-day cross
No cross
Price vs 200-day avg
−83%
below
Price vs 50-day avg
−59%
below
RSI (14)
25
oversold
MACD trend
Negative
52-week position
0%
near low
Volume (OBV)
Confirms
volume backs price
Momentum
relative strength
1-month return
−57%
trailing
6-month return
−85%
trailing
YTD return
−59%
this year
Relative strength
−91%
vs S&P · 6-mo
Sentiment
smart money
Trend (MA cross)
No cross
50d $2 › 200d $5 — 200d above 50d
Institutional flow
Distributing
-88% holders QoQ · +1 funds added
Insider flow
Flat
No net insider activity over 90 days
Short interest
Rising
1.92% of float · ▲ +7.6% MoM · 1.2 days cover
Volume signal
Reversal watch
High volume on a down day — possible exhaustion
Institution breadth
Multi-yr low
1 holders — near 3-yr low, contrarian setup
Fundamentals
EPS growth
−1325%
Y/Y
Free cash flow
$-45.2M
Balance sheet
$50.8M
net cash
Quant / Vol
risk profile
Volatility
121%
annualized · 1-yr
Max drawdown
−93%
past year
ATR
34.1%
of price · 14-day
Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.
Technicals
trend & momentum for long-term holders Strong Sell
50 / 200-day cross
No cross
Neutral
Price vs 200-day avg
−83%
Bearish
Price vs 50-day avg
−59%
Bearish
RSI (14)
25
Neutral
MACD trend
Negative
Bearish
52-week position
0%
Bearish
Volume (OBV)
Confirms
Neutral
Market signals — smart money & positioning
Bearish · 2 of 6
Trend (MA cross)
No cross
50d $2 › 200d $5 — 200d above 50d
Institutional flow
Distributing
-88% holders QoQ · +1 funds added
Insider flow
Flat
No net insider activity over 90 days
Short interest
Rising
1.92% of float · ▲ +7.6% MoM · 1.2 days cover
Volume signal
Reversal watch
High volume on a down day — possible exhaustion
Institution breadth
Multi-yr low
1 holders — near 3-yr low, contrarian setup
Price context
position in its 52-week range
Range low $1
Now $1 · 0%
Range high $13
vs 200-day avg -83%
vs 50-day avg -59%
Illustrative technical + ownership context — a signal mix, not investment advice.
Versus peers
Medical Devices — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
RBOT
this stock
Vicarious Surgical Inc.
|
$284,969 | -58.6% | — | — | 1.9% |
|
ABT
Abbott Laboratories
|
$191.81B | -13.1% | +5.7% | 30.9 | 1.2% |
|
SYK
Stryker Corp
|
$126.84B | -9.7% | +11.2% | 34.3 | 1.8% |
|
MDT
Medtronic plc
|
$116.78B | -4.2% | +8.4% | 24.5 | 1.1% |
|
BSX
Boston Scientific Corp
|
$70.00B | -49.6% | +12.5% | 19.6 | 1.9% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every sectionOwnership
Short & Settlement
Financials
Filings
Performance
Raw-price comparisons begin at the captured split on Jun 13, 2024; windows that need an earlier baseline remain unavailable.
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| RBOT | -55.3% | -57.0% | -85.5% | -55.9% | -58.6% |
| SPY | -1.2% | -0.6% | +5.1% | -0.1% | +0.5% |
| vs SPY | -54.1% | -56.4% | -90.5% | -55.8% | -59.0% |